Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hilary R. Hernan"'
Autor:
Peter H. Johnson, Jules H. Blank, Tien Hoang, Toby C. Campbell, Chong Zhang, KyungMann Kim, Anne M. Traynor, Harish Ahuja, Jill M. Kolesar, Mary E. Wims, Michael S. Huie, Emily Robinson, Hilary R. Hernan, Ron J. Kirschling, Kurt R. Oettel, Martha M. Larson
Publikováno v:
Investigational New Drugs. 32:195-199
Introduction The primary objective of this phase II trial was to evaluate the efficacy and tolerability of vorinostat and bortezomib as third-line therapy in advanced non-small cell lung cancer (NSCLC) patients. Methods Eligibility criteria included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29eab44cb18d05d6442bf3c55f86f82
https://doi.org/10.1007/s10637-013-9980-5
https://doi.org/10.1007/s10637-013-9980-5
Autor:
Kurt R. Oettel, Toni M. Brand, Chong Zhang, Mari Iida, Toby C. Campbell, David T. Yang, Anne M. Traynor, Tien Hoang, Hilary R. Hernan, Ravi Salgia, Deric L. Wheeler, Tracey L. Weigel, KyungMann Kim
Introduction Nuclear EGFR (nEGFR) has been identified in various human tumor tissues, including cancers of the breast, ovary, oropharynx, and esophagus, and has predicted poor patient outcomes. We sought to determine if protein expression of nEGFR is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a76746bcc604fa1072af7cbf2fa259
https://europepmc.org/articles/PMC3679338/
https://europepmc.org/articles/PMC3679338/
Autor:
Kyle D. Holen, Kurt R. Oettel, Timothy Goggins, Hilary R. Hernan, Anne M. Traynor, Sam J. Lubner, Emily Robinson, William R. Schelman, Daniel Mulkerin, Dustin A. Deming, David Groteluschen, Noelle K. LoConte
Publikováno v:
Investigational new drugs. 31(4)
Chemotherapy has yielded minimal clinical benefit in pancreatic and biliary tract cancer. A high-dose, short course capecitabine schedule with oxaliplatin, has shown some efficacy with a lower incidence of palmar-plantar erythrodysesthesia. Achieving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c2ee1b6c5fc4ad1c446101ecf562d3
https://pubmed.ncbi.nlm.nih.gov/23263993
https://pubmed.ncbi.nlm.nih.gov/23263993
Autor:
Gilbert G. Fareau, Jules H. Blank, Kari B. Wisinski, Anne M. Traynor, Ryan J. Mattison, Hilary R. Hernan, Glen Leverson, Diane F Elson, Martha M. Larson, Herbert Chen, Rebecca S. Sippel
Publikováno v:
Journal of Clinical Oncology. 31:e17025-e17025
e17025 Background: Histone deacetylase (HDAC) inhibitors suppress tumor cell proliferation in medullary thyroid cancer (MTC) and differentiated thyroid cancer (DTC) in vivo. We conducted a multicenter single arm phase II trial of panobinostat, a pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbe80d954d713469be57e6ec9c3234b8
https://doi.org/10.1200/jco.2013.31.15_suppl.e17025
https://doi.org/10.1200/jco.2013.31.15_suppl.e17025
Autor:
Emily Robinson, Jules H. Blank, Toby C. Campbell, R. J. Kirschling, Hilary R. Hernan, Anne M. Traynor, Chong Zhang, Michael S. Huie, M. W. Jones, Jill M. Kolesar, M. B. Wims, Kurt R. Oettel, P. H. Johnson, Harish G. Ahuja, Tien Hoang
Publikováno v:
Journal of Clinical Oncology. 29:7567-7567
7567 Background: Third-line treatment option for advanced NSCLC patients is very limited with a lack of effective drugs and specific trials targeting this patient population. V+B combination was pr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::001b2cf99381ff35f601b42bdf80d8d9
https://doi.org/10.1200/jco.2011.29.15_suppl.7567
https://doi.org/10.1200/jco.2011.29.15_suppl.7567